GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

Symbol: ANVS on NYSE
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$768,711	222,132	+37,978	+21%	$3.46	Q4 2025
30 Sep 2025	0%	0%	$381,283	184,154	+867	+0.47%	$2.07	Q3 2025
30 Jun 2025	0%	+0%	$397,814	183,287	+30,674	+20%	$2.17	Q2 2025
31 Mar 2025	0%	+0%	$228,988	152,613	+53,049		$1.50	Q1 2025
31 Dec 2024	0%	0%	$501,037	99,564	+450	+0.45%	$5.03	Q4 2024
30 Sep 2024	0%	+0%	$798,989	99,114	+22,881	+30%	$8.06	Q3 2024
30 Jun 2024	0%	+0%	$439,199	76,233	+5,442	+7.7%	$5.76	Q2 2024
31 Mar 2024	0%	+0%	$842,606	70,791	+2,015	+2.9%	$11.90	Q1 2024
31 Dec 2023	0%	+0%	$1,286,390	68,776	+12,736	+23%	$18.70	Q4 2023
30 Sep 2023	0%	+0%	$531,975	56,040	+4,390	+8.5%	$9.49	Q3 2023
30 Jun 2023	0%	0%	$738,078	51,650	0		$14.29	Q2 2023
31 Mar 2023	0%	+0%	$795,926	51,650	+8,092	+19%	$15.41	Q1 2023
31 Dec 2022	0%	+0%	$584,000	43,558	+1,262	+3%	$13.41	Q4 2022
30 Sep 2022	0%	0%	$579,000	42,296	0		$13.69	Q3 2022
30 Jun 2022	0%	0%	$479,000	42,296	+269	+0.64%	$11.32	Q2 2022
31 Mar 2022	0%	+0%	$561,000	42,027	+1,082	+2.6%	$13.35	Q1 2022
31 Dec 2021	0%	0%	$719,000	40,945	0		$17.56	Q4 2021
30 Sep 2021	0%	+0%	$1,300,000	40,945	+2,376	+6.2%	$31.75	Q3 2021
30 Jun 2021	0%	+0%	$3,300,000	38,569	+10,986	+40%	$85.56	Q2 2021
31 Mar 2021	0%	+0%	$769,000	27,583	+27,583	NEW	$27.88	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.